EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma

Angélica Luna-Nophal, Fernando Díaz-Castillo, Vanessa Izquierdo-Sánchez iD, Jesús B Velázquez-Fernández, Mario Orozco-Morales, Luis Lara-Mejía iD, Johana Bernáldez-Sarabia iD, Noemí Sánchez-Campos iD, Oscar Arrieta iD, José Díaz-Chávez iD, Jorge-Ismael Castañeda-Sánchez iD, Alexei-Fedorovish Licea-Navarro und 1 weitere

Marine Drugs · 2025

DOI: 10.3390/md23010032 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Marine Drugs, 2025. Verfasst von Angélica Luna-Nophal und 12 weiteren Autor:innen. Beteiligte Einrichtung: Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Ciudad de Mexico 04960, Mexico. Hauptthemen laut MEDLINE: Mesothelioma, Malignant, Antineoplastic Agents, Conotoxins, Pleural Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Instituto Nacional de Cancerologia-Mexico, CICESE, CONAHCyT-Mexico.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Malignant pleural mesothelioma (MPM) is a rare neoplasm with increasing incidence and mortality rates. Although recent advances have improved the overall prognosis, they have not had an important impact on survival of patients with MPM, such that more effective treatments are needed. Some species of marine snails have been demonstrated to be potential sources of novel anticancer molecules. This study analyzed the anticancer effects in vitro and in vivo of two peptides found in C. californicus. The effects of s-cal14.1b and s-cal14.2b on cell proliferation, apoptosis, and cytotoxicity were evaluated in 2D and 3D cultures of MPM-derived cells. Proteomics analysis of 3D cultures treated with conotoxins was performed to examine changes in expression or abundance. And the therapeutic effects of both conotoxins were evaluated in MPM mouse xenografts. s-cal14.1b and s-cal14.2b induced apoptosis and cytotoxicity in 2D and 3D cultures. However, only s-cal14.1b modified spheroid growth. Approximately 600 proteins exhibited important differential expression, which was more heterogeneous in H2452 vs MSTO-211H spheroids. The in silico protein functional analysis showed modifications in the biological pathways associated with carcinogenesis. CAPN1, LIMA1, ANXA6, HUWE1, PARP1 or PARP4 proteins could be potential cell targets for conotoxins and serve as biomarkers in MPM. Finally, we found that both conotoxins reduced the tumor mass in MPM xenografts; s-cal14.1b reached statistical significance. Based on these results, s-cal14.1b and s-cal14.2b conotoxins could be potential therapeutic drugs for MPM neoplasms with no apparent side effects on normal cells.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mesothelioma, MalignantAntineoplastic AgentsConotoxinsPleural NeoplasmsMesotheliomaLung NeoplasmsConus SnailAnimalsHumansProteomicsMiceCell Line, TumorApoptosisCell ProliferationXenograft Model Antitumor Assays

Stichwörter der Autor:innen

marine toxinsmass spectrometrypharmacological activityprotein markerstherapeutic effect

Substanzen

Antineoplastic AgentsConotoxins

Autor:innen und Institutionen

  • Doctorado en Ciencias Biológicas y de la Salud, Universidad Autónoma Metropolitana, Ciudad de Mexico 04960, Mexico.
  • Laboratorio de Oncología Experimental, Subdirección de Investigación Básica, Instituto Nacional de Cancerología, Ciudad de Mexico 14080, Mexico.
  • Departamento de Innovación Biomédica, Centro de Investigación Científica y de Educación Superior de Ensenada (CICESE), Ensenada 22860, Mexico.
  • Control de Calidad, Unidad Ciclotrón & Radiofarmacia, Instituto Nacional de Cancerología, Ciudad de Mexico 14080, Mexico.
  • CONAHCyT-Investigador por Mexico, Ciudad de Mexico 14080, Mexico.
  • Departamento de Biotecnología y Bioingeniería, Centro de Investigación y de Estudios Avanzados-IPN, Ciudad de Mexico 07360, Mexico.

ORCID-Profile: Vanessa Izquierdo-Sánchez, Luis Lara-Mejía, Johana Bernáldez-Sarabia, Noemí Sánchez-Campos, Oscar Arrieta, José Díaz-Chávez, Jorge-Ismael Castañeda-Sánchez, Saé Muñiz-Hernández

Förderung

  • Instituto Nacional de Cancerologia-Mexico
  • CICESE
  • CONAHCyT-Mexico

Zitieren

APA

Luna-Nophal, A., Díaz-Castillo, F., Izquierdo-Sánchez, V., Velázquez-Fernández, J. B., Orozco-Morales, M., Lara-Mejía, L., Bernáldez-Sarabia, J., Sánchez-Campos, N., Arrieta, O., Díaz-Chávez, J., Castañeda-Sánchez, J. I., Licea-Navarro, A. F., & Muñiz-Hernández, S. (2025). Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs. https://doi.org/10.3390/md23010032

Vancouver

Luna-Nophal A, Díaz-Castillo F, Izquierdo-Sánchez V, Velázquez-Fernández JB, Orozco-Morales M, Lara-Mejía L, et al. Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma. Marine Drugs. 2025. doi:10.3390/md23010032

BibTeX
@article{LunaNophal2025,
  author = {Luna-Nophal, Angélica and Díaz-Castillo, Fernando and Izquierdo-Sánchez, Vanessa and Velázquez-Fernández, Jesús B and Orozco-Morales, Mario and Lara-Mejía, Luis and Bernáldez-Sarabia, Johana and Sánchez-Campos, Noemí and Arrieta, Oscar and Díaz-Chávez, José and Castañeda-Sánchez, Jorge-Ismael and Licea-Navarro, Alexei-Fedorovish and Muñiz-Hernández, Saé},
  title = {Preclinical Efficacy and Proteomic Prediction of Molecular Targets for s-cal14.1b and s-cal14.2b Conotoxins with Antitumor Capacity in Xenografts of Malignant Pleural Mesothelioma},
  journal = {Marine Drugs},
  year = {2025},
  doi = {10.3390/md23010032}
}
Kostenlos starten →